Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Oncology
Reference27 articles.
1. Rahman FA, Naidu J, Ngiu CS, Yaakob Y, Mohamed Z, Othman H, et al. Conventional versus doxorubicin-eluting beads transarterial chemoembolization for unresectable hepatocellular carcinoma: a tertiary medical centre experience in Malaysia. Asian Pac J Cancer Prev. 2016;17(8):4037.
2. Stewart BW, Wild Ceoc. ebrary I. World cancer report 2014: Lyon, France. Geneva: WHO Press, World Health Organization: International Agency for Research on Cancer; 2014.
3. El-Serag BH. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 2002;35(5 Suppl 2):S72–S8.
4. Wallace MC, Preen DB, Short MW, Adams LA, Jeffrey GP. Hepatocellular carcinoma in Australia 1982-2014: increasing incidence and improving survival. Liver Int. 2019;39(3):522–30.
5. Song MJ, Chun HJ, Song DS, Kim HY, Yoo SH, Park CH, et al. Comparative study between doxorubicin-eluting beads and conventional transarterial chemoembolization for treatment of hepatocellular carcinoma. J Hepatol. 2012;57(6):1244–50.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献